Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inhibition of erythrocyte sickling in vitro by pyridoxal.
J A Kark, … , M Woods, L S Lessin
J A Kark, … , M Woods, L S Lessin
Published October 1, 1978
Citation Information: J Clin Invest. 1978;62(4):888-891. https://doi.org/10.1172/JCI109202.
View: Text | PDF
Research Article

Inhibition of erythrocyte sickling in vitro by pyridoxal.

  • Text
  • PDF
Abstract

To test the antisickling activity of pyridoxal, we compared the oxygen affinity and the percent sickling at low PO2 of untreated erythrocytes with values for cells from the same blood sample incubated with pyridoxal, glyceraldehyde, or pyridoxine. Pyridoxal increased oxygen affinity much more than glyceraldehyde. 20 mM pyridoxal and glyceraldehyde had equivalent antisickling activity. At PO2 levels above 20 mm Hg, both agents reduced sickling to less than 2%. In samples examined by electron microscopy, pyridoxal reduced the percent sickled cells and the percent cells that contain hemoglobin S fibers by the same amount (from 74 to 3%). Pyridoxine had no effect on oxygen affinity or sockling. Pyridoxal reacts with intracellular hemoglobin to increase oxygen affinity, which inhibits hemoglobin S polymerization and sickling.

Authors

J A Kark, M P Kale, P G Tarassoff, M Woods, L S Lessin

×

Total citations by year

Year: 2020 2017 2011 2002 1997 1987 1986 1983 1982 1981 Total
Citations: 1 1 2 1 1 1 1 3 1 1 13
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (13)

Title and authors Publication Year
Polymerization of deoxygenated sickle hemoglobin in the presence of fractionated leaf extracts of Anacardium occidentale, Psidium guajava, and Terminalia catappa
PC Chikezie, RC Ekeanyanwu, AB Chile-Agada
2020
Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii: Antioxidant properties and global metabolite screening of probiotic yeast
S Datta, DJ Timson, US Annapure
Journal of the Science of Food and Agriculture 2017
Sodium metabisulfite-induced polymerization of sickle cell hemoglobin incubated in the extracts of three medicinal plants (Anacardium occidentale, Psidium guajava, and Terminalia catappa)
PC Chikezie
Pharmacognosy magazine 2011
Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control
JR Miranda-Massari, MJ Gonzalez, FJ Jimenez, MZ Allende-Vigo, J Duconge
Current clinical pharmacology 2011
Vitamin B6 Status of Children With Sickle Cell Disease
MC Nelson, BS Zemel, DA Kawchak, EM Barden, EA Frongillo, SP Coburn, K Ohene-Frempong, VA Stallings
Journal of Pediatric Hematology/Oncology 2002
Shifts in affinity and enthalpy of oxygen binding to human hemoglobin A induced by pyridoxal and pyridoxal 5′-phosphate
JA Westrick, CR Johnson, JH Simmons, A Smolen
The Journal of Nutritional Biochemistry 1997
6 Rheology of the sickle cell disorders
J Stuart, CS Johnson
Baillière's Clinical Haematology 1987
Covalent binding of glutathione to hemoglobin. I. Inhibition of hemoglobin S polymerization
MC Garel, C Domenget, J Caburi-Martin, C Prehu, F Galacteros, Y Beuzard
The Journal of biological chemistry 1986
Pyridoxal phosphate as an antisickling agent in vitro
JA Kark, PG Tarassoff, R Bongiovanni
Journal of Clinical Investigation 1983
Schiff base adducts of glyceraldehyde with hemoglobin. Differences in the Amadori rearrangement at the alpha-amino groups
AS Acharya, LG Sussman, JM Manning
The Journal of biological chemistry 1983
Specific modification of the carboxyl groups of hemoglobin S
R Seetharam, JM Manning, AS Acharya
The Journal of biological chemistry 1983
A rapid fluorometric assay for erythrocyte pyridoxal kinase
JA Kark, MJ Haut, CU Hicks, CT McQuilkin, RD Reynolds
Biochemical Medicine 1982
The Molecular Basis of Mutant Hemoglobin Dysfunction
DR Harkness
The Molecular Basis of Mutant Hemoglobin Dysfunction 1981

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts